Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-17 16:14:57 ET
Genmab A/S (GMAB) Q4 2025 Earnings Call February 17, 2026 12:00 PM EST
Company Participants
Jan van de Winkel - Co-Founder, President & CEO
Brad Bailey
Anthony Pagano - Executive VP & CFO
Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of Experimental Medicines
Judith Klimovsky - Executive VP & Chief Development Officer
...
Read the full article on Seeking Alpha
For further details see:
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Genmab
NASDAQ: GNMSF
GNMSF Trading
0.0% G/L:
$290 Last:
7 Volume:
$290 Open:
GNMSF Latest News
GNMSF Stock Data
$20,431,984,318
64,554,266
N/A
758
N/A
Biotechnology & Life Sciences
Healthcare
DK
Valby
